Lactulose Breath Testing as a Predictor of Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea

The nonsystemic antibiotic rifaximin is indicated for irritable bowel syndrome with diarrhea (IBS-D) in adults; however, determinants of response remain unclear. The utility of lactulose breath testing (LBT) in predicting response to rifaximin was examined. METHODS: Adults with IBS-D received open-l...

Descripción completa

Detalles Bibliográficos
Autores principales: Rezaie, Ali, Heimanson, Zeev, McCallum, Richard, Pimentel, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6903366/
https://www.ncbi.nlm.nih.gov/pubmed/31688023
http://dx.doi.org/10.14309/ajg.0000000000000444

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6903366/
https://www.ncbi.nlm.nih.gov/pubmed/31688023
http://dx.doi.org/10.14309/ajg.0000000000000444

Ejemplares similares